Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05818683 |
Title | A Study of JNJ-78278343 in Combination With JNJ-63723283 (Cetrelimab) for Metastatic Castration-Resistant Prostate Cancer |
Recruitment | Recruiting |
Gender | male |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Janssen Research & Development, LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Florida Cancer Specialists | RECRUITING | Sarasota | Florida | 34232 | United States | Details |
Start Midwest | RECRUITING | Grand Rapids | Michigan | 49546 | United States | Details |
NYU Langone Health | RECRUITING | New York | New York | 10016 | United States | Details |
Macquarie University | RECRUITING | Macquarie University | 2109 | Australia | Details | |
Peter MacCallum Cancer Centre | RECRUITING | Melbourne | 3000 | Australia | Details | |
Princess Alexandra Hospital | RECRUITING | Woolloongabba | 4102 | Australia | Details |